$VTAE Vitae Pharmaceuticals, Inc Insider Trading
Get free email notifications about insider trading in Vitae Pharmaceuticals, Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vitae Pharmaceuticals, Inc. Insider overview, share value development, latest insider transactions and email notifications about new events in Vitae Pharmaceuticals, Inc for free.
CIK Number: 0001157602
IRS Number: 043567753
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: VTAE
Company Address: 502 WEST OFFICE CENTER DR FORT WASHINGTON 19034
Phone number: 215-461-2000
Former name: CONCURRENT PHARMACEUTICALS INC, date of change: 2001-08-15
Former name: Vitae Pharmaceuticals Inc, date of change: 2005-01-18
Prev close: $21.00
Average Daily Volume: 1,047,240
Days Low: $0.00
Year Low: $4.08
Year High: $21.03
Vitae Pharmaceuticals, Inc Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 8.78 | 16,500 | 144,870 | 0 | |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 8.58 | 32,750 | 280,995 | 0 | |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 8.28 | 21,250 | 175,950 | 0 | |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 14.40 | 14,306 | 206,006 | 0 | |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Option Exercise | D | 7.13 | 21,647 | 154,343 | 0 | |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gregg Richard | Chief Science Offic ... | Sell | D | 21.00 | 228,274 | 4,793,754 | 228,274 | 456.5 K to 228.3 K (-50.00 %) |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Rowland Charles A Jr | Director | Option Exercise | D | 9.62 | 10,000 | 96,200 | 0 | |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Rowland Charles A Jr | Director | Option Exercise | D | 12.43 | 10,000 | 124,300 | 0 | |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Rowland Charles A Jr | Director | Option Exercise | D | 8.00 | 17,000 | 136,000 | 0 | |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | LEONARD JOHN M. | Director | Option Exercise | D | 9.62 | 10,000 | 96,200 | 0 | |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | LEONARD JOHN M. | Director | Option Exercise | D | 9.85 | 20,000 | 197,000 | 0 | |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Option Exercise | D | 9.62 | 10,000 | 96,200 | 0 | |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Option Exercise | D | 12.43 | 10,000 | 124,300 | 0 | |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Option Exercise | D | 8.00 | 17,000 | 136,000 | 0 | |
Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Gunderson Robert V JR | Director | Option Exercise | D | 5.29 | 9,091 | 48,091 | 0 |